Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITALE: High vs Low Dose Vitamin D in Renal Transplant Recipients
NCT01431430Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2012
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vitamin d in type 2 diabetes mellitus (T2DM), cardiovascular diseases (CVD) and cancer (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Composite of de novo diabetes mellitus, cardiovascular complications, de novo cancer, and patient death at 2 years. Started Jan 2012; status: completed.
02
Drugs
vitamin d
03
Conditions
type 2 diabetes mellitus (T2DM)cardiovascular diseases (CVD)cancer
Beyond the preview
Go deeper on NCT01431430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01431430.